Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification

Journal of Medical Virology
Naoko YoshidaTetsuo Nakayama

Abstract

Clinically apparent mumps reinfection is considered extremely rare, but several cases have been suspected of reinfection in an out-patient clinic. In this study, virological examination, virus isolation, the reverse transcription loop-mediated isothermal amplification (RT-LAMP), and IgG and IgM EIA antibodies, were examined in order to identify mumps reinfection. Patients were divided into three categories; the reinfection group comprised 29 patients with a history of natural infection, the vaccine-failure group consisted of 37 patients with an immunization history, and two patients had histories of both immunization and mumps infection. Another 25 patients were enrolled as a primary infection group. Mumps virus was isolated in 5 (17%) and the genome was detected in 12 (41%) of 29 in the reinfection group. Reinfection was confirmed in 21/28, demonstrating high avidity of IgG EIA. Mumps virus was isolated in 15 (41%) and there was a higher positivity of genome amplification in 25 (68%) of 37 patients in the vaccine-failure group. Among these, 23 were confirmed as secondary vaccine failure by high avidity IgG EIA serology. In the primary infection group, the isolation rate and genome detection rate was higher in 16 (64%) and in 1...Continue Reading

References

Jan 1, 1995·Journal of Medical Virology·J P GutA Kirn
Jun 1, 1996·Acta Paediatrica Japonica; Overseas Edition·M KimuraR Murata
Nov 5, 1998·Clinical and Diagnostic Laboratory Immunology·M NaritaT Togashi
Jun 28, 2000·Nucleic Acids Research·T NotomiT Hase
Sep 15, 2001·Archives of Virology·S UsukuN Kobayashi
May 27, 2003·Journal of Medical Virology·Claudia VinagreMaría Eugenia Pinto
Mar 26, 2004·Journal of Medical Virology·Yoko InouChiaki Miyazaki
May 28, 2004·Journal of Biochemical and Biophysical Methods·Yasuyoshi MoriTsugunori Notomi
Jul 13, 2004·Vaccine·Corinne VandermeulenKarel Hoppenbrouwers
Feb 3, 2005·The Journal of Infectious Diseases·Irja DavidkinHeikki Peltola
Apr 9, 2005·Journal of Clinical Microbiology·Takao OkafujiTetsuo Nakayama
Jun 14, 2005·Vaccine·Richard HarlingCorry van den Bosch
Nov 18, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Martin DonaghyVera Friederichs
Aug 31, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Gaynor Watson-CreedTodd F Hatchette

❮ Previous
Next ❯

Citations

Apr 10, 2012·Molecular Biotechnology·Francesca SidotiRossana Cavallo
Sep 12, 2012·The Journal of Infectious Diseases·Mia KontioIrja Davidkin
Aug 13, 2013·The Journal of Infectious Diseases·Albert E BarskeyGregory S Wallace
Jan 16, 2009·Journal of Clinical Microbiology·Musa Y HindiyehElla Mendelson
Jul 19, 2013·PloS One·Keita MatsubaraTetsuo Nakayama
Aug 29, 2014·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·M HukicJ M Hubschen
Jan 5, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Keita MatsubaraTetsuo Nakayama
Nov 7, 2009·Clinics in Laboratory Medicine·Wenjuan Wu, Yi-Wei Tang
Apr 28, 2009·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yasuyoshi Mori, Tsugunori Notomi
May 30, 2008·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Jelena Ivancic-JeleckiDubravko Forcic
Apr 8, 2011·Emerging Infectious Diseases·Chee Fu YungMary Ramsay
Sep 13, 2015·Vaccine·Eduardo Santacruz-SanmartínFrancisco J Díaz
Jun 6, 2015·Human Vaccines & Immunotherapeutics·Patricia KaaijkCécile A van Els
May 8, 2015·PLoS Pathogens·Donald R Latner, Carole J Hickman
Apr 23, 2017·Pediatrics International : Official Journal of the Japan Pediatric Society·Kihei TeradaKazunobu Ouchi
Jul 1, 2017·Central European Journal of Public Health·Miroslav FajfrJana Fajfrová
Dec 29, 2013·Clinical and Vaccine Immunology : CVI·Donald R LatnerCarole J Hickman
Feb 28, 2020·Clinical Microbiology Reviews·Eugene LamJane R Zucker
Feb 2, 2020·Scientific Reports·Rosa Ester ForgioneAlba Silipo
Sep 5, 2019·Proceedings of the National Academy of Sciences of the United States of America·Mohammed Ata Ur RasheedSrilatha Edupuganti
Sep 28, 2016·Proceedings of the National Academy of Sciences of the United States of America·Marie KubotaTakao Hashiguchi
May 3, 2018·Journal of the Pediatric Infectious Diseases Society·Stanley A Plotkin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.